Antiobesity Medications in Adult and Pediatric Obesity and Metabolic DysfunctionAssociated Steatotic Liver Disease
As of 2019, semaglutide is the only GLP-1 receptor agonist to receive FDA approval in an oral formulation
Treat them as refrigerated medications and minimize time at room temperature
Compounded medications from licensed pharmacies use the same active molecule as branded drugs but are not FDA-approved for safety, efficacy, or quality
Pueden aparecer molestias gastrointestinales, fundamentalmente nuseas y diarrea, si bien son sntomas habitualmente leves o moderados que se manifiestan al inicio del proceso teraputico y que suelen desaparecer a los pocos das o en pocas semanas, cuando se estabiliza el tratamiento, remarca Sacristn
Cambios visuales : Visin borrosa o cambios en la visin pueden indicar retinopata diabtica que empeora